Elexacaftor Helpful in Cystic Fibrosis Patients Homozygous for F508del Elexacaftor Helpful in Cystic Fibrosis Patients Homozygous for F508del

Elexacaftor, in combination with tezacaftor and ivacaftor, improved outcomes in patients with cystic fibrosis (CF) homozygous for the F508del mutation, in a phase 3 trial.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
More News: Cystic Fibrosis | Health